Device Survival Probability
D154VWC,D164VWC_SURV
| 1 yr | 2 yr | 3 yr | 4 yr | 5 yr | 6 yr | 7 yr | 8 yr | 9 yr | 10 yr | 11 yr | 12 yr | 13 yr | 14 yr | at 175.0 mo | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % |  |
100.0 | 100.0 | 99.9 | 99.7 | 98.1 | 96.8 | 96.7 | 96.6 | 96.5 | 96.5 | 96.4 | 96.4 | 96.4 | 96.4 | 96.4 | ||||||
| % |  |
99.8 | 99.6 | 99.3 | 98.8 | 96.0 | 87.7 | 77.4 | 60.3 | 44.3 | 31.8 | 22.6 | 17.9 | 16.1 | 15.1 | 14.2 | ||||||
| # | 28533 | 26122 | 23727 | 21527 | 19157 | 16192 | 13280 | 9318 | 6090 | 3936 | 2463 | 1591 | 1144 | 623 | 179 |
- Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
- Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Customer Communications For This Model
- There are no communications for this model.
Product Characteristics
| Generator Type | ICD |
|---|---|
| NBD Code | VVE-VVIR |
| Max. Delivered Energy | 35 J |
| Connector Style | Cx Style |
|---|---|
| Serial Number Prefix | PUP |
| Mass | 68 g |
| Volume | 37 cc |
| Waveform | Biphasic |
| X-Ray ID | PVR |
Estimated Longevity
| Charging Frequency | 100% Pacing | 50% Pacing | 15% Pacing | 100% Sensing |
|---|---|---|---|---|
| Monthly | 4.8 | 5.1 | 5.3 | 5.4 |
| Quarterly | 8.1 | 9.0 | 9.6 | 10.0 |
| Semi-annual | 10.0 | 11.2 | 12.3 | 12.9 |
Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content
Distribution Data
| US Market Release | |
|---|---|
| CE Approval Date | 2006-03-07 |
| Registered USA Implants | 1 |
| Estimated Active USA Implants | 1 |
| Normal Battery Depletions |
| US Market Release | |
|---|---|
| CE Approval Date | 2006-03-07 |
| Estimated WW Distribution | 14374 |
| Normal Battery Depletions | 268 |
Malfunctions (USA)
| Therapy Function Not Compromised | |
|---|---|
| Therapy Function Compromised |
Malfunctions (WW)
| Therapy Function Not Compromised | 424 |
|---|---|
| Battery | 5 |
| Electrical Component | 413 |
| Possible Early Battery Depletion | 3 |
| Software/Firmware | 1 |
| Other | 2 |
| Therapy Function Compromised | 13 |
| Battery | 1 |
| Electrical Component | 12 |
EOS Indication
EOS device status is defined as 3 months following an RRT indication assuming the following PSP conditions: 100% VVI pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and 6 full-energy charges. EOS may be indicated before the end of 3 months if the device exceeds these conditions.
Recommended Replacement (RRT)
Battery voltage less than or equal to 2.62V on 3 consecutive daily automatic measurments.
Charge Time
D154VWC_D164VWC_CHRG
Data as of May 10, 2023